Back to mobile site

Ladenburg Thalmann Starts Aptevo Therapeutics (APVO) at Buy

November 5, 2018 7:10 AM EST Send to a Friend
Ladenburg Thalmann analyst Wangzhi Li initiates coverage on Aptevo Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login